Skip to main content
Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
10.36
-0.51 (-4.69%)
At close: Nov 13, 2026, 4:00 PM EST
9.62
-0.74 (-7.16%)
After-hours: Nov 13, 2026, 7:30 PM EST

Climb Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
6091911217498278
Market Cap Growth
364.83%57.83%62.54%-23.65%-64.90%-
Enterprise Value
38216-97-33-32108
Last Close Price
10.364.001.802.703.6710.46

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
2.621.190.570.690.761.66
P/TBV Ratio
2.671.190.570.690.761.66

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.010.000.000.000.00-
Net Debt / Equity Ratio
-0.99-1.00-1.00-0.99-0.96-0.96
Net Debt / EBITDA Ratio
3.412.36----
Net Debt / FCF Ratio
4.222.9413.625.173.294.47
Quick Ratio
25.9814.4730.6138.5721.3523.79
Current Ratio
26.5815.1631.4138.9222.0424.58
Return on Equity (ROE)
-29.28%-32.15%-46.26%-29.72%-30.58%-50.16%
Return on Assets (ROA)
-19.92%-22.04%-10.30%-10.93%-18.30%-22.54%
Return on Capital Employed (ROCE)
-29.20%-42.20%-12.70%-19.90%-35.00%-21.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-7.94%-31.34%-61.07%-47.17%-46.40%-17.09%
FCF Yield
-8.81%-28.56%-12.86%-27.67%-38.33%-12.99%
Buyback Yield / Dilution
-6.58%-40.80%-78.47%-2.57%-114.60%-460.40%
SEC Filings: 10-K · 10-Q